Drug Shortage Report for APO-GABAPENTIN

Last updated on 2017-10-04 History
Report ID 20000
Drug Identification Number 02244304
Brand name APO-GABAPENTIN CAPSULES
Common or Proper name GABAPENTIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 & 500 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-21
Estimated end date 2017-09-29
Actual end date 2017-09-29
Shortage status Resolved
Updated date 2017-10-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-10-04 French Compare
v6 2017-10-04 English Compare
v5 2017-08-29 French Compare
v4 2017-08-29 English Compare
v3 2017-08-22 English Compare
v2 2017-08-21 French Compare
v1 2017-08-21 English Compare

Showing 1 to 7 of 7